Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering
December 20, 2024
Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019
April 13, 2022
Related Post
-
-
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
December 20, 2024
-
INOVIO Announces Pricing of $30 Million Public Offering
December 13, 2024
-
Lumos Pharma and Double Point Ventures Announce Successful Completion of Tender Offer and Double Point Ventures’ Acquisition of Lumos Pharma
December 12, 2024